风险因素与垂体神经内分泌瘤之间的关联:双向的门德尔随机化研究
Wencai Wang1, Luyao Ma, Menghao Liu
1The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Medicine
|January 14, 2025
概括
门德尔的随机化发现,增加体力活动可能会增加垂体神经内分泌瘤的风险. 相反,过敏性疾病,慢性病和更长的睡眠时间似乎对这些瘤有保护作用.
科学领域:
- 内分泌学 在内分泌学.
- 遗传学 是一个遗传学.
- 流行病学 流行病学
背景情况:
- 下垂体神经内分泌瘤 (PitNETs) 的确切原因尚不清楚.
- 了解风险因素对于制定有效的预防策略至关重要.
研究的目的:
- 利用孟德尔随机化研究生活方式和慢性疾病风险因素对PitNET发展的潜在因果影响.
主要方法:
- 采用孟德尔的随机化分析,将多个遗传变异作为工具变量.
- 评估了8种风险因素:3种生活方式 (体力活动,睡眠时间,特定活动) 和5种慢性疾病.
- 利用各种统计方法,包括反变量加权和MR-Egger回归来进行强大的因果推断和灵敏度分析.
主要成果:
- 基因预测的较高水平的中度至剧烈的体力活动与PitNET发病率的增加有关 (OR = 5.21).
- 过敏性疾病 (OR = 0.81),慢性病 (OR = 0.67),睡眠时间增加 (OR = 0.07) 和游泳或骑自行车 (OR = 0.02) 等特定的体力活动显示与减少PitNETs风险相关.
- 对于其余的风险因素,没有发现任何显著的关联.
结论:
- 过敏性疾病,慢性病,睡眠时间和某些身体活动可能在垂体神经内分泌瘤的发展中发挥保护作用.
- 增加中度至剧烈的体力活动可能是PitNETs的危险因素,需要进一步调查.
- 这些发现强调需要在流行病学研究中重新评估因果关系,以完善对PitNET的理解和预防.
相关概念视频
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
01:12Hazard Ratio
83
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
83
01:33Pleiotropy
39.6K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
39.6K
01:19Psychoneuroimmunology: Diabetes and Cancer
22
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
22
01:28Criteria for Causality: Bradford Hill Criteria - II
195
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
195
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K